ES2185460A1 - Microparticula de liberacion prolongada y metodo para su preparacion. - Google Patents

Microparticula de liberacion prolongada y metodo para su preparacion.

Info

Publication number
ES2185460A1
ES2185460A1 ES200002485A ES200002485A ES2185460A1 ES 2185460 A1 ES2185460 A1 ES 2185460A1 ES 200002485 A ES200002485 A ES 200002485A ES 200002485 A ES200002485 A ES 200002485A ES 2185460 A1 ES2185460 A1 ES 2185460A1
Authority
ES
Spain
Prior art keywords
sustained release
dispersed
preparing
microparticles
emulsions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES200002485A
Other languages
English (en)
Other versions
ES2185460B1 (es
Inventor
Jin Kyu Park
Mork Soon Park
Dong Scon Kim
Il Ho Lim
Ung Kil Jee
Pyung Keun Myung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dong Kook Pharmaceutical Co Ltd
Original Assignee
Dong Kook Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dong Kook Pharmaceutical Co Ltd filed Critical Dong Kook Pharmaceutical Co Ltd
Publication of ES2185460A1 publication Critical patent/ES2185460A1/es
Application granted granted Critical
Publication of ES2185460B1 publication Critical patent/ES2185460B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
    • H05B6/00—Heating by electric, magnetic or electromagnetic fields
    • H05B6/64—Heating using microwaves
    • H05B6/80—Apparatus for specific applications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02B—CLIMATE CHANGE MITIGATION TECHNOLOGIES RELATED TO BUILDINGS, e.g. HOUSING, HOUSE APPLIANCES OR RELATED END-USER APPLICATIONS
    • Y02B40/00—Technologies aiming at improving the efficiency of home appliances, e.g. induction cooking or efficient technologies for refrigerators, freezers or dish washers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Electromagnetism (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Glanulating (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Biological Depolymerization Polymers (AREA)

Abstract

Micropartícula de liberación prolongada y método para su preparación. Se describe un método para preparar micropartículas de liberación prolongada que liberan una sustancia fisiológicamente activa durante periodos de tiempo prolongados. Se prepara las micropartículas de liberación prolongada mediante un proceso multiemulsión. Se disuelve o se dispersa una droga de interés en cada uno de por lo menos dos aceites para dar al menos dos fases o emulsiones de aceites primarias. Cada fase o emulsión de aceite contiene un polímero biodegradable. Las dos fases o emulsiones de aceite primarias por lo menos se dispersan en una fase acuosa, de manera síncrona o en sucesión. De la solución dispersada de la droga se retira los disolventes orgánicos para producir micropartículas. Por consiguiente, las drogas tales como hormonas liberadoras de hormona luteinizante pueden liberarse continuamente in vivo durante periodos de tiempo prolongados, consiguiéndose una mejora en el efecto terapéutico.
ES200002485A 2000-06-28 2000-10-17 Microparticula de liberacion prolongada y metodo para su preparacion. Expired - Fee Related ES2185460B1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR2000-36178 2000-06-28
KR20000036178A KR100392501B1 (ko) 2000-06-28 2000-06-28 다중 에멀젼법에 의한 서방출성 미립구의 제조방법

Publications (2)

Publication Number Publication Date
ES2185460A1 true ES2185460A1 (es) 2003-04-16
ES2185460B1 ES2185460B1 (es) 2004-06-16

Family

ID=19674602

Family Applications (1)

Application Number Title Priority Date Filing Date
ES200002485A Expired - Fee Related ES2185460B1 (es) 2000-06-28 2000-10-17 Microparticula de liberacion prolongada y metodo para su preparacion.

Country Status (16)

Country Link
US (1) US6506410B1 (es)
JP (1) JP3641418B2 (es)
KR (1) KR100392501B1 (es)
CN (1) CN1330921A (es)
BR (2) BR0005287A (es)
CA (1) CA2317769C (es)
DE (1) DE10045374B4 (es)
ES (1) ES2185460B1 (es)
FR (1) FR2810885B1 (es)
GB (1) GB2363986B (es)
IN (1) IN189017B (es)
IT (1) IT1320273B1 (es)
MX (1) MXPA00009408A (es)
PL (1) PL348343A1 (es)
TR (1) TR200003123A2 (es)
ZA (1) ZA200004485B (es)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1216037A2 (en) * 1999-09-21 2002-06-26 Emory University Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
US6458387B1 (en) * 1999-10-18 2002-10-01 Epic Therapeutics, Inc. Sustained release microspheres
WO2002043580A2 (en) 2000-10-27 2002-06-06 Epic Therapeutics, Inc. Production of microspheres
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
EP1418890B1 (en) * 2001-08-16 2008-05-14 Baxter International Inc. Propellant-based microparticle formulations
US20080026068A1 (en) * 2001-08-16 2008-01-31 Baxter Healthcare S.A. Pulmonary delivery of spherical insulin microparticles
GB0129489D0 (en) * 2001-12-10 2002-01-30 Quadrant Healthcare Uk Ltd Sustained-release compositions
US20050064039A1 (en) * 2001-12-26 2005-03-24 Tomomichi Futo Novel microsphere and method for production thereof
WO2004016083A1 (ja) * 2002-08-19 2004-02-26 Nagoya Industrial Science Research Institute 球脊髄性筋萎縮症の病態を再現する非ヒト動物、及び球脊髄性筋萎縮症治療剤
WO2004058844A1 (ja) * 2002-12-25 2004-07-15 E-Tec Co., Ltd. 樹脂微粒子及び樹脂マイクロカプセル、並びにそれらの製造方法
DE10315640A1 (de) * 2003-04-04 2004-10-14 Ignatov, Konstantin Verfahren zur kontrollierten Freisetzung von Komponenten in eine Lösung
US20040210118A1 (en) * 2003-04-18 2004-10-21 Michel Letort In situ detection of endoleak and endotension
US20040213767A1 (en) * 2003-04-23 2004-10-28 Marc Hendriks Methods for using adipose-derived cells for healing of aortic aneurysmal tissue
US20040215318A1 (en) * 2003-04-24 2004-10-28 Brian Kwitkin Timed delivery of therapeutics to blood vessels
US7387645B2 (en) * 2003-04-25 2008-06-17 Medtronic Vascular, Inc. Cellular therapy to heal vascular tissue
US20040215335A1 (en) * 2003-04-25 2004-10-28 Brin David S. Methods and apparatus for treatment of aneurysmal tissue
US20040215320A1 (en) * 2003-04-25 2004-10-28 James Machek Integral stent graft
US7396540B2 (en) * 2003-04-25 2008-07-08 Medtronic Vascular, Inc. In situ blood vessel and aneurysm treatment
US20040254629A1 (en) * 2003-04-25 2004-12-16 Brian Fernandes Methods and apparatus for treatment of aneurysmal tissue
SE526027C2 (sv) 2003-05-23 2005-06-14 Gambro Lundia Ab Biokompatibel polymerkomposition, förfarande för beredning av en biokompatibel sampolymerkomposition, artikel med en film av en polymerkomposition och användning av en biokompatibel polymerkomposition för en medicinsk anordning
DE602004028234D1 (de) * 2003-05-23 2010-09-02 Gambro Lundia Ab Biokompatibles polymer
US20070092452A1 (en) * 2003-07-18 2007-04-26 Julia Rashba-Step Methods for fabrication, uses, compositions of inhalable spherical particles
WO2005035088A2 (en) * 2003-07-18 2005-04-21 Baxter International, Inc. Method for preparing small spherical by controlled phase separation
US20050142205A1 (en) * 2003-07-18 2005-06-30 Julia Rashba-Step Methods for encapsulating small spherical particles prepared by controlled phase separation
JP2007508240A (ja) * 2003-07-22 2007-04-05 バクスター・インターナショナル・インコーポレイテッド 低分子量有機分子の小球状粒子ならびにその調製方法および使用方法
US20050043786A1 (en) * 2003-08-18 2005-02-24 Medtronic Ave, Inc. Methods and apparatus for treatment of aneurysmal tissue
US7371228B2 (en) * 2003-09-19 2008-05-13 Medtronic Vascular, Inc. Delivery of therapeutics to treat aneurysms
CN1314453C (zh) * 2003-09-25 2007-05-09 中国科学院过程工程研究所 尺寸均一、储存稳定的亲水性药物的复乳载体及其制备方法
TW200529890A (en) 2004-02-10 2005-09-16 Takeda Pharmaceutical Sustained-release preparations
EP1753404A1 (en) 2004-05-12 2007-02-21 Baxter International Inc. Microspheres comprising protein and showing injectability at high concentrations of said agent
CA2566079A1 (en) * 2004-05-12 2005-12-01 Terrence L. Scott Nucleic acid microspheres, production and delivery thereof
US8728525B2 (en) * 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
WO2005112885A2 (en) * 2004-05-12 2005-12-01 Baxter International Inc. Oligonucleotide-containing microspheres, their use for the manufacture of a medicament for treating diabetes type 1
US20050266043A1 (en) * 2004-05-27 2005-12-01 Medtronic Vascular, Inc. Methods and compounds for treatment of aneurysmal tissue
US8048409B2 (en) * 2004-05-27 2011-11-01 Medtronic Vascular, Inc. Cellular therapy to heal vascular tissue
US20050266042A1 (en) * 2004-05-27 2005-12-01 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysmal tissue
EP2594259A1 (en) * 2004-08-04 2013-05-22 Brookwood Pharmaceuticals, Inc. Methods for manufacturing delivery devices and devices thereof
US9000040B2 (en) 2004-09-28 2015-04-07 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
US9012506B2 (en) 2004-09-28 2015-04-21 Atrium Medical Corporation Cross-linked fatty acid-based biomaterials
WO2007011385A2 (en) 2004-09-28 2007-01-25 Atrium Medical Corporation Heat cured gel and method of making
MX2007013356A (es) * 2005-04-27 2008-03-26 Baxter Int Microparticulas modificadas en la superficie y metodos de formacion y uso de las mismas.
EP1933764A2 (en) * 2005-09-02 2008-06-25 Medtronic Vascular, Inc. Methods and apparatus for treatment of aneurysms adjacent to branch arteries
US9427423B2 (en) 2009-03-10 2016-08-30 Atrium Medical Corporation Fatty-acid based particles
CN1939316B (zh) * 2005-09-28 2012-01-25 中国人民解放军军事医学科学院毒物药物研究所 含阿霉素的微球及其制备方法
US9278161B2 (en) * 2005-09-28 2016-03-08 Atrium Medical Corporation Tissue-separating fatty acid adhesion barrier
US20080286375A1 (en) * 2005-11-15 2008-11-20 Amorepacific Corporation Method for Preparing Sustained-Release Microparticles Comprising Sucrose Acetate Isobutyrate
RU2464972C2 (ru) * 2005-12-22 2012-10-27 Новартис Аг Композиции с замедленным высвобождением, включающие октреотид и два или более сополимера полилактида и гликолида
KR100722607B1 (ko) * 2006-05-11 2007-05-28 주식회사 펩트론 분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
US20070281031A1 (en) * 2006-06-01 2007-12-06 Guohan Yang Microparticles and methods for production thereof
KR100801194B1 (ko) * 2006-07-14 2008-02-11 한국과학기술원 세포 배양 및 전달용 다공성 생분해성 고분자 미립 담체와그의 제조방법
EP2647712A3 (en) * 2006-08-04 2013-11-20 Baxter International Inc Microsphere-based composition for preventing and/or reversing new-onset autoimmune diabetes
US8202524B2 (en) 2006-08-31 2012-06-19 Sk Chemicals Co., Ltd. Method for producing microspheres loaded with drugs and microspheres loaded with drugs produced thereby
WO2008060786A2 (en) * 2006-10-06 2008-05-22 Baxter International Inc. Microencapsules containing surface-modified microparticles and methods of forming and using the same
KR100845009B1 (ko) * 2007-08-07 2008-07-08 한국생명공학연구원 전하를 띠는 물질이 고착된 다공성 고분자 입자 및 그제조방법
EP2222284B1 (en) * 2007-11-19 2020-07-01 Capsulated Systems Inc. Prolonged release of local anesthetics using microparticles and surgery applications
CA2709712C (en) 2007-12-20 2016-05-10 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles having a low residual solvent volume
KR101005562B1 (ko) 2008-05-01 2011-01-05 한국생명공학연구원 난용성 약물을 함유하는 균일한 크기의 고분자 나노입자제조방법
US8697098B2 (en) * 2011-02-25 2014-04-15 South Dakota State University Polymer conjugated protein micelles
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
KR100963435B1 (ko) 2008-06-19 2010-06-17 한국과학기술연구원 서방형 약물전달 및 조직재생용 덮인 다공성 생분해성고분자 미립구의 제조 방법
US8034382B2 (en) * 2008-07-31 2011-10-11 The Board Of Trustees Of The University Of Arkansas Preparation method for biodegradable micro-particles containing drugs
US8323615B2 (en) * 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing multi-phasic dispersions
US8323685B2 (en) 2008-08-20 2012-12-04 Baxter International Inc. Methods of processing compositions containing microparticles
US20100047292A1 (en) * 2008-08-20 2010-02-25 Baxter International Inc. Methods of processing microparticles and compositions produced thereby
US8367427B2 (en) * 2008-08-20 2013-02-05 Baxter International Inc. Methods of processing compositions containing microparticles
US20100131051A1 (en) * 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Systems and Methods for Treatment of Aneurysms Using Zinc Chelator(s)
US20100131001A1 (en) * 2008-11-24 2010-05-27 Medtronic Vascular, Inc. Targeted Drug Delivery for Aneurysm Treatment
US20100152832A1 (en) * 2008-12-12 2010-06-17 Medtronic Vascular, Inc. Apparatus and Methods for Treatment of Aneurysms With Fibrin Derived Peptide B-Beta
WO2010085607A1 (en) * 2009-01-23 2010-07-29 Surmodics Pharmaceuticals, Inc. Continuous double emulsion process for making microparticles
KR101663561B1 (ko) * 2009-02-18 2016-10-10 동국제약 주식회사 서방출성 미립구의 제조방법
CN101530396A (zh) * 2009-04-15 2009-09-16 西安力邦医药科技有限责任公司 氨氯地平微球的制备方法
KR101105292B1 (ko) * 2009-06-05 2012-01-17 주식회사 리젠 바이오텍 생분해성 고분자 미세입자와 그의 제조방법
US20110038910A1 (en) 2009-08-11 2011-02-17 Atrium Medical Corporation Anti-infective antimicrobial-containing biomaterials
JP5675820B2 (ja) * 2009-09-22 2015-02-25 エボニック コーポレイションＥｖｏｎｉｋ Ｃｏｒｐｏｒａｔｉｏｎ 様々な生物活性剤担持構成を有するインプラントデバイス
USRE49251E1 (en) 2010-01-04 2022-10-18 Mapi Pharma Ltd. Depot systems comprising glatiramer or pharmacologically acceptable salt thereof
EP2593141B1 (en) 2010-07-16 2018-07-04 Atrium Medical Corporation Composition and methods for altering the rate of hydrolysis of cured oil-based materials
KR20120048811A (ko) * 2010-11-08 2012-05-16 에스케이케미칼주식회사 아나스트로졸 함유 고분자 미립구를 유효성분으로 포함하는 약학적 조성물
KR101785515B1 (ko) * 2010-11-08 2017-10-16 에스케이케미칼주식회사 올란자핀 함유 고분자 미립구를 유효성분으로 포함하는 약학적 조성물
KR101411349B1 (ko) 2010-12-24 2014-06-25 주식회사 삼양바이오팜 생리활성 펩타이드를 포함하는 마이크로입자 및 그의 제조방법, 및 그를 포함하는 약제학적 조성물
JP2014518842A (ja) 2011-02-25 2014-08-07 サウス ダコタ ステート ユニバーシティー ポリマーコンジュゲートタンパク質ミセル
KR101481859B1 (ko) * 2011-05-20 2015-01-14 에스케이케미칼주식회사 초기 약물 방출이 감소된 고분자 미립자의 제조방법 및 그 방법에 의해 제조된 고분자 미립자
CN102389756B (zh) * 2011-08-11 2014-01-01 长春金赛药业有限责任公司 复乳法制备微球的方法
US9867880B2 (en) 2012-06-13 2018-01-16 Atrium Medical Corporation Cured oil-hydrogel biomaterial compositions for controlled drug delivery
EP2981276A4 (en) 2013-04-05 2017-03-22 Claudia Zylberberg Matrix metalloproteinases and uses thereof
CN103211773B (zh) * 2013-04-10 2014-11-05 上海丽珠制药有限公司 一种制备醋酸亮丙瑞林微球的方法
KR101543507B1 (ko) * 2013-05-15 2015-08-11 씨제이헬스케어 주식회사 연속 공정의 미립구의 제조 방법 및 이로부터 제조된 미립구
CN103724635B (zh) * 2013-12-06 2016-01-20 中国烟草总公司郑州烟草研究院 一种醋酸纤维素多孔微球的制备方法及其产品
CN103766351B (zh) * 2014-02-14 2015-11-04 国家纳米科学中心 一种纳米农药组合物及其制备方法
KR101558083B1 (ko) * 2014-04-07 2015-10-07 에스케이케미칼주식회사 약물함유 고분자미립구 제조방법
TW201618783A (zh) 2014-08-07 2016-06-01 艾森塔製藥公司 以布魯頓(Bruton)氏酪胺酸激酶(BTK)佔據和BTK再合成速率為基礎之治療癌症、免疫和自體免疫疾病及發炎性疾病之方法
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
CN109982712A (zh) 2016-08-31 2019-07-05 Mapi医药公司 包含醋酸格拉替雷的储库系统
BR112019017724A2 (pt) 2017-03-26 2020-03-31 Mapi Pharma Ltd. Sistemas depot de glatiramer para tratar formas progressivas de esclerose múltipla
CN107412171B (zh) * 2017-04-21 2020-04-17 湖南赛隆药业有限公司 注射用左旋泮托拉唑钠长效微球冻干制剂及其制备方法
KR102142026B1 (ko) * 2017-05-31 2020-08-06 주식회사 대웅제약 방출제어가 용이한 서방성 약물 미립자의 제조방법
CN109316371B (zh) * 2018-09-21 2021-09-03 珀莱雅化妆品股份有限公司 一种芹菜素缓释制剂的制备方法
US12274787B2 (en) 2018-12-17 2025-04-15 G2Gbio, Inc. Sustained-release injection comprising deslorelin, and preparation method therefor
CN110403736A (zh) * 2019-08-09 2019-11-05 常州市第二人民医院 一种3d打印超多孔钛合金促成骨表面改性方法
DE102019126672B4 (de) * 2019-10-02 2021-07-01 Universität Rostock Wirkstoffdepotsystem sowie Kit zur in situ Polymerisation des Wirkstoffdepotsystems
CN111249524B (zh) * 2020-01-18 2020-12-08 南京医科大学附属口腔医院 用于骨组织再生的高孔隙率聚己内酯多孔微球支架及其制备方法
CN111658620B (zh) * 2020-04-30 2022-04-19 天津医科大学口腔医院 一种透明质酸-帕瑞昔布plga微球及其制备方法和应用
IL300547A (en) * 2020-08-18 2023-04-01 Oakwood Laboratories LLC Microsphere formulations comprising ketamine and methods for their production and use
JP7522402B2 (ja) * 2021-02-26 2024-07-25 熊本県 塩化ビニル系ポリマー粒子の製造方法
CN113648283B (zh) * 2021-07-23 2023-11-07 丽水市中心医院 靶向抑制HIF-2α的载药微球制备方法、载药微球及应用

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
FR2679788A1 (fr) * 1991-08-02 1993-02-05 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5576064A (en) * 1993-03-11 1996-11-19 Roussel Uclaf Multiple emulsions
EP0779071A1 (fr) * 1995-12-15 1997-06-18 L'oreal Emulsion E/H/E stable contenant un actif cosmétique et/ou dermatologique sensible à l'eau
FR2763005A1 (fr) * 1997-05-07 1998-11-13 Henkel Kgaa Procede de fabrication d'emulsions e/h/e multiples
FR2766737A1 (fr) * 1997-07-31 1999-02-05 Centre Nat Rech Scient Emulsions multiples et leurs applications

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT74025B (de) * 1914-10-16 1917-11-26 Siemens Ag Verfahren und Herstellung einer Mauer im Erdreich.
US4495509A (en) * 1983-06-09 1985-01-22 Moore Business Forms, Inc. Microencapsulation by interchange of multiple emulsions
AR240875A1 (es) * 1984-01-09 1991-03-27 Stauffer Chemical Co Procedimiento para producir capsulas de poliurea de dimensiones multiples que contienen un material inmiscible en agua en su interior y las capsulas resultantes
EP0190833B1 (en) * 1985-02-07 1991-03-27 Takeda Chemical Industries, Ltd. Method for producing microcapsule
HU221294B1 (en) * 1989-07-07 2002-09-28 Novartis Ag Process for producing retarde compositions containing the active ingredient in a polymeric carrier
US5478564A (en) * 1990-02-22 1995-12-26 Teva Pharmaceutical Industries, Ltd. Preparation of microparticles for controlled release of water-soluble substances
JPH04247230A (ja) * 1991-02-01 1992-09-03 Fuji Photo Film Co Ltd マイクロカプセルの製造方法およびそれを用いた感光材料
JP3790567B2 (ja) * 1994-09-30 2006-06-28 武田薬品工業株式会社 徐放剤
DE19545257A1 (de) * 1995-11-24 1997-06-19 Schering Ag Verfahren zur Herstellung von morphologisch einheitlichen Mikrokapseln sowie nach diesem Verfahren hergestellte Mikrokapseln
US6287587B2 (en) * 1997-07-15 2001-09-11 Takeda Chemical Industries, Ltd. Process for producing sustained-release preparation by in-water drying

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
FR2679788A1 (fr) * 1991-08-02 1993-02-05 Thorel Jean Noel Structures d'emulsions polyphasiques autostabilisees.
US5576064A (en) * 1993-03-11 1996-11-19 Roussel Uclaf Multiple emulsions
EP0779071A1 (fr) * 1995-12-15 1997-06-18 L'oreal Emulsion E/H/E stable contenant un actif cosmétique et/ou dermatologique sensible à l'eau
FR2763005A1 (fr) * 1997-05-07 1998-11-13 Henkel Kgaa Procede de fabrication d'emulsions e/h/e multiples
FR2766737A1 (fr) * 1997-07-31 1999-02-05 Centre Nat Rech Scient Emulsions multiples et leurs applications

Also Published As

Publication number Publication date
BRPI0005287B1 (pt) 2019-01-22
FR2810885A1 (fr) 2002-01-04
IN189017B (es) 2002-12-07
IT1320273B1 (it) 2003-11-26
TR200003123A2 (tr) 2002-01-21
DE10045374B4 (de) 2007-08-30
ITTO20000963A1 (it) 2002-04-13
MXPA00009408A (es) 2002-03-15
ZA200004485B (en) 2001-02-28
CA2317769C (en) 2005-03-15
ES2185460B1 (es) 2004-06-16
BR0005287A (pt) 2002-02-13
FR2810885B1 (fr) 2003-10-17
GB2363986A (en) 2002-01-16
ITTO20000963A0 (it) 2000-10-13
KR20020000698A (ko) 2002-01-05
JP2002020269A (ja) 2002-01-23
DE10045374A1 (de) 2002-01-24
CA2317769A1 (en) 2001-12-28
PL348343A1 (en) 2002-01-02
GB2363986B (en) 2002-12-11
CN1330921A (zh) 2002-01-16
US6506410B1 (en) 2003-01-14
KR100392501B1 (ko) 2003-07-22
JP3641418B2 (ja) 2005-04-20
GB0020992D0 (en) 2000-10-11

Similar Documents

Publication Publication Date Title
CA2317769A1 (en) Sustained release microparticle and method for preparing the same
ATE380541T1 (de) Herstellung von vitaminemulsionen und konzentrate davon
Kranz et al. In vitro and in vivo drug release from a novel in situ forming drug delivery system
MXPA01012106A (es) Matrices porosas de farmaco y metodo de fabricacion de las mismas.
BRPI0415858A (pt) compostos de medicamentos terapêuticos modificados por tocoferol
CR7654A (es) Una combinacion de azelatina y esteroides
WO2004039426A8 (en) Transdermal delivery system for water insoluble drugs
JP2019528277A (ja) カリオフィレンを用いた局所領域的神経作用療法
ATE269080T1 (de) Mikrokapsel mit verzögerter freigabe für wasserlösliche arzneistoffe
WO2000074661A3 (en) Solubility enhancement of drugs in transdermal drug delivery systems and methods of use
ATE235235T1 (de) Arzneistoffverabreichungssystem auf basis von flüssigkristall-strukturen
AR012854A1 (es) Una composicion de suministro de droga para la liberacion controlada de un ingrediente activo en el ambiente estomacal por un periodo de tiempoprolongado, una composicion farmaceutica que la comprende, el uso de dicha composicion en la fabricacion de un medicamento, un proceso para la preparacion
GR920100323A (el) Μία μέ?οδος παρασκευής μικροσφαιρίων αποτελούμενων από ένα βιοαποικοδομούμενο πολυμερικό υλικό.
KR930701989A (ko) 친유성 약제용 이상의 방출제제
KR20180088415A (ko) 국소적 막형성 스프레이
AR037629A1 (es) Formulaciones farmaceuticas que comprenden un derivado de platino
CY1109661T1 (el) 5-cnac ως παραγοντας για χορηγηση απο το στομα τμηματων παραθορμονης
CA2611147C (en) Topical emulsion formulation
AR034640A1 (es) Composicion de liberacion sostenida y proceso para producirla
Abu‐Huwaij et al. Recent exploration of nanoemulsions for drugs and cosmeceuticals delivery
DE59912782D1 (de) Topisches Arzneimittel mit einem Gehalt an Ciclosporin
DE69922017D1 (de) Arzneimittel und verfahren zur behandlung von intrazellulären infektionen
NO20024737D0 (no) Farmasöytiske preparater og fremstilling derav
Dua et al. Aceclofenac topical dosage forms: in vitro and in vivo characterization
EA201101246A1 (ru) Инъекционная лекарственная форма для лечения острого ишемического инсульта и черепно-мозговой травмы, способ ее изготовления и применение

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 20030416

Kind code of ref document: A1

FG2A Definitive protection

Ref document number: 2185460B1

Country of ref document: ES

FD2A Announcement of lapse in spain

Effective date: 20211118